185 related articles for article (PubMed ID: 23392891)
1. Differential regulation of TauT by calcitriol and retinoic acid via VDR/RXR in LLC-PK1 and MCF-7 cells.
Chesney RW; Han X
Adv Exp Med Biol; 2013; 776():291-305. PubMed ID: 23392891
[TBL] [Abstract][Full Text] [Related]
2. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
3. Retinoid X receptors in the kidney: their protein expression and functional significance.
Sugawara A; Sanno N; Takahashi N; Osamura RY; Abe K
Endocrinology; 1997 Aug; 138(8):3175-80. PubMed ID: 9231765
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D represses retinoic acid-dependent transactivation of the retinoic acid receptor-beta2 promoter: the AF-2 domain of the vitamin D receptor is required for transrepression.
Jiménez-Lara AM; Aranda A
Endocrinology; 1999 Jun; 140(6):2898-907. PubMed ID: 10342883
[TBL] [Abstract][Full Text] [Related]
5. Allosteric interaction of the 1alpha,25-dihydroxyvitamin D3 receptor and the retinoid X receptor on DNA.
Kahlen JP; Carlberg C
Nucleic Acids Res; 1997 Nov; 25(21):4307-13. PubMed ID: 9336462
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors.
Pathrose P; Barmina O; Chang CY; McDonnell DP; Shevde NK; Pike JW
J Bone Miner Res; 2002 Dec; 17(12):2196-205. PubMed ID: 12469913
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D3- and retinoic acid-induced monocytic differentiation: interactions between the endogenous vitamin D3 receptor, retinoic acid receptors, and retinoid X receptors in U-937 cells.
Botling J; Oberg F; Törmä H; Tuohimaa P; Bläuer M; Nilsson K
Cell Growth Differ; 1996 Sep; 7(9):1239-49. PubMed ID: 8877104
[TBL] [Abstract][Full Text] [Related]
8. Selective recognition of vitamin D receptor conformations mediates promoter selectivity of vitamin D analogs.
Quack M; Carlberg C
Mol Pharmacol; 1999 Jun; 55(6):1077-87. PubMed ID: 10347251
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer cell type-specific involvement of the VDR and RXR in regulation of the human PTHrP gene via a negative VDRE.
Sepulveda VA; Weigel NL; Falzon M
Steroids; 2006 Feb; 71(2):102-15. PubMed ID: 16243370
[TBL] [Abstract][Full Text] [Related]
10. Regulation of TauT by cisplatin in LLC-PK1 renal cells.
Han X; Chesney RW
Pediatr Nephrol; 2005 Aug; 20(8):1067-72. PubMed ID: 15942793
[TBL] [Abstract][Full Text] [Related]
11. 9-cis retinoic acid accelerates calcitriol-induced osteocalcin production and promotes degradation of both vitamin D receptor and retinoid X receptor in human osteoblastic cells.
Jääskeläinen T; Ryhänen S; Mäenpää PH
J Cell Biochem; 2003 Aug; 89(6):1164-76. PubMed ID: 12898515
[TBL] [Abstract][Full Text] [Related]
12. Ligand occupancy is not required for vitamin D receptor and retinoid receptor-mediated transcriptional activation.
Matkovits T; Christakos S
Mol Endocrinol; 1995 Feb; 9(2):232-42. PubMed ID: 7776973
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D and vitamin A receptor expression and the proliferative effects of ligand activation of these receptors on the development of pancreatic progenitor cells derived from human fetal pancreas.
Ng KY; Ma MT; Leung KK; Leung PS
Stem Cell Rev Rep; 2011 Mar; 7(1):53-63. PubMed ID: 20354914
[TBL] [Abstract][Full Text] [Related]
14. 1 alpha,25-dihydroxyvitamin D3 transrepresses retinoic acid transcriptional activity via vitamin D receptor in myeloid cells.
Bastie JN; Balitrand N; Guidez F; Guillemot I; Larghero J; Calabresse C; Chomienne C; Delva L
Mol Endocrinol; 2004 Nov; 18(11):2685-99. PubMed ID: 15284334
[TBL] [Abstract][Full Text] [Related]
15. Distinct retinoid X receptor activation function-2 residues mediate transactivation in homodimeric and vitamin D receptor heterodimeric contexts.
Thompson PD; Remus LS; Hsieh JC; Jurutka PW; Whitfield GK; Galligan MA; Encinas Dominguez C; Haussler CA; Haussler MR
J Mol Endocrinol; 2001 Oct; 27(2):211-27. PubMed ID: 11564604
[TBL] [Abstract][Full Text] [Related]
16. [The regulation of vitamin D3 and 9-cis-retinoic acid and their receptors on human hsp90 beta gene].
Zhang H; Wu N; Shen Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Aug; 22(4):322-6. PubMed ID: 12903442
[TBL] [Abstract][Full Text] [Related]
17. Synthetic LXXLL peptide antagonize 1,25-dihydroxyvitamin D3-dependent transcription.
Pike JW; Pathrose P; Barmina O; Chang CY; McDonnell DP; Yamamoto H; Shevde NK
J Cell Biochem; 2003 Feb; 88(2):252-8. PubMed ID: 12520523
[TBL] [Abstract][Full Text] [Related]
18. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
19. Structural variants of the vitamin D analogue EB1089 reduce its ligand sensitivity and promoter selectivity.
Quack M; Clarin A; Binderup E; Björkling F; Hansen CM; Carlberg C
J Cell Biochem; 1998 Dec; 71(3):340-50. PubMed ID: 9831071
[TBL] [Abstract][Full Text] [Related]
20. Interaction of GABA-mimetics with the taurine transporter (TauT, Slc6a6) in hyperosmotic treated Caco-2, LLC-PK1 and rat renal SKPT cells.
Rasmussen RN; Lagunas C; Plum J; Holm R; Nielsen CU
Eur J Pharm Sci; 2016 Jan; 82():138-46. PubMed ID: 26631583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]